Large Cap / Pharmaceuticals, Biotechnology & Life Sciences
PFE Obtains FDA Approval for Lyrica

Pfizer FDA Approval Received

June 21, 2012

On June 21, 2012, Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved the use of Lyrica® (pregabalin) capsules CV for the management of neuropathic pain associated with spinal cord injury.

To view the full article, please subscribe or login.

Free Report

George Putnam has suceessfully invested in distressed companies for nearly 30 years and The Turnaround Letter's market-beating returns demonstrate the profit potential. He knows all the pitfalls, too--which he shares in this free report!

stock market advice

stock market advice

Distressed Investing Blog

Distressed Investing Blog

2015 Sale Recommendations Gain 69%

10 of 2015's 12 sale recommendations have seen profits. Four of those stocks--GLW, WEN, FCH and BLDR--enjoyed total returns of 100% or higher, and our readers locked in an average gain of 69% with this year's closed out stock picks. Read More.

Your Financial Security is Serious Business...

so why should you trust The Turnaround Letter?

  • Ranked as #1 Performing Newsletter for 15-Yr. Returns: Turnaround Letter's 12.3% vs. S&P's 2.2%
  • 29+ Years of Turnaround Investing Experience & Reliable Stock Market Advice
  • Diverse Monthly Stock Picks Personally Selected by George Putnam

2015 Stock Profit

George Putnam's Turnaround Letter has seen considerable stock profit in 2015: 10 of this year's 12 sale recommendations have seen increases.

Four of those enjoyed total returns of 100% or higher--and 2015's closed out stock picks have realized an average gain of 69% thus far.

 

2015 Stock Picks

 

Value Stock Profit